Roche beat first-quarter sales expectations Thursday, while Sanofi's sales report came in mixed. Shares were muted in ...

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 ...

Bristol Myers Squibb reported higher-than-expected first-quarter revenue on Thursday and raised its full-year forecast due to ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Trump hosted the CEOs of Walmart, Target and Home Depot to talk tariffs. Tesla reports earnings after the bell Tuesday.

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

On CNBC's “Halftime Report Final Trades ,” Joshua Brown of Ritholtz Wealth Management picked CrowdStrike Holdings, Inc. CRWD ...

For example, in pharmaceutical companies, patents are necessary owing to the ease with which some drugs can be replicated. Similarly, patents are vital in the medical-device industry to protect ...

The online business platform LinkedIn has revealed the best companies in Switzerland to work for in 2025. A clear trend has emerged from the data: nearly all the ‘winners’ are in the pharmaceutical or ...

Then Trump threatened that pharma won't be spared either, renewing anxiety. Still, one corner of the sector offers hope. Companies focusing on the Indian pharmaceutical market are likely to offer ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...